Emerging Longevity Ventures logo

Emerging Longevity Ventures

North America, Florida, United States, West Palm Beach

Description

Emerging Longevity Ventures is a venture capital firm.

Investor Profile

Emerging Longevity Ventures has made 5 investments, with 1 in the past 12 months and 20% as lead.

Stage Focus

  • Seed (100%)

Country Focus

  • United Kingdom (60%)
  • United States (20%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Emerging Longevity Ventures frequently co-invest with?

Infinita Fund
North America, Islas de la Bahia, Honduras, Roatán
Co-Investments: 1
Longevitytech.fund
North America, Florida, United States, Boca Raton
Co-Investments: 2
TI
Asia, Shanghai, China, Shanghai
Co-Investments: 3
LV
North America, Connecticut, United States, Norwalk
Co-Investments: 1
VitaDAO
North America, Ontario, Canada, Ottawa
Co-Investments: 1
Healthspan Capital
North America, California, United States, El Cerrito
Co-Investments: 1
1517 Fund
North America, California, United States, Oakland
Co-Investments: 1
QantX
Europe, Devon, United Kingdom, Exeter
Co-Investments: 2
APEX Ventures
Europe, Wien, Austria, Vienna
Co-Investments: 2
R42 Group
North America, California, United States, Stanford
Co-Investments: 3

Which angels does Emerging Longevity Ventures often collaborate with?

JM
Europe, Isle of Man
Shared Deals: 1
Balaji Srinivasan
Asia, Central Region, Singapore, Singapore
Shared Deals: 1
KP
North America, California, United States, San Francisco
Shared Deals: 1
TE
North America, Massachusetts, United States, Boston
Shared Deals: 1
Shared Deals: 1
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Emerging Longevity Ventures?

ImmuneAGE Bio is a drug discovery platform focused on rejuvenating the immune system.

BiotechnologyHealth Care
SeedJul 12, 2024
Amount Raised: $2,000,000
Senisca

Exeter, Devon, United Kingdom

Senisca is a biotech spinout company that creates a new generation of oligonucleotide-based interventions.

BiotechnologyHealth Care
SeedMar 18, 2024
Amount Raised: $4,708,943
Senisca

Exeter, Devon, United Kingdom

Senisca is a biotech spinout company that creates a new generation of oligonucleotide-based interventions.

BiotechnologyHealth Care
SeedJun 9, 2022
Amount Raised: $2,498,545
Senisca

Exeter, Devon, United Kingdom

Senisca is a biotech spinout company that creates a new generation of oligonucleotide-based interventions.

BiotechnologyHealth Care
SeedMar 5, 2021
Amount Raised: $1,798,591
Repair Biotechnologies

Syracuse, New York, United States

Repair Biotechnologies is a biotechnology company developing therapies based on the cholesterol-degrading platform.

BiotechnologyHealth CareMedical
SeedMay 7, 2019
Amount Raised: $2,150,000